First approval of inflammation inhibitor in CVD by FDA

10' education - July 25, 2023 - Paul Ridker, MD - Boston, MA, USA

Educational information

This video was recorded in response to the recent decision of the FDA of approving an anti-inflammatory therapy for CVD.

Faculty

Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our news item on this topic

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.